Petros Pharmaceuticals to effect 1-for-25 reverse stock split

The compny intends to effect a reverse stock split of its common stock, par value $0.0001 per share at a ratio of 1 post-split share for every 25 pre-split shares. The reverse stock split will become effective at 4:05 p.m. on Wednesday, April 30, 2025. The Company’s common stock will continue to be traded on the Nasdaq Capital Market under the symbol “PTPI” and will begin trading on a split-adjusted basis when the market opens on Thursday, May 1, 2025. The new CUSIP number for the common stock following the reverse stock split is 71678J308. At the 2024 annual meeting of stockholders held on November 20, 2024, the Company’s stockholders granted the Company’s Board of Directors the discretion to effect a reverse stock split of the Company’s common stock through an amendment to its Amended and Restated Certificate of Incorporation, as amended, at a ratio of not less than 1-for-2 and not more than 1-for-25, with such ratio to be determined by the Company’s Board of Directors.